Daiwa Securities Group Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 18 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$637,000
+48.8%
886,000
+39.3%
0.01%
+25.0%
Q3 2019$428,000
-3.2%
636,0000.0%0.00%0.0%
Q2 2019$442,000636,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$23,311,0005.66%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 44,492,000$39,153,0001.56%
UBS OCONNOR LLC 26,000,000$23,448,000,0000.34%
Saltoro Capital, LP 750,000$678,0000.17%
AQR Arbitrage LLC 3,050,000$2,758,0000.10%
WATER ISLAND CAPITAL LLC 1,500,000$1,371,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 3,448,000$3,103,0000.07%
OAKTREE CAPITAL MANAGEMENT LP 5,780,000$5,227,0000.07%
Teton Advisors, Inc. 400,000$358,0000.05%
MACQUARIE GROUP LTD 8,175,000$7,393,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders